Nova R Wealth Inc. decreased its holdings in shares of BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 3.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 320,242 shares of the company’s stock after selling 12,727 shares during the period. BlackRock Health Sciences Trust accounts for about 6.1% of Nova R Wealth Inc.’s portfolio, making the stock its 3rd biggest position. Nova R Wealth Inc.’s holdings in BlackRock Health Sciences Trust were worth $12,147,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently made changes to their positions in BME. Fountainhead AM LLC acquired a new position in BlackRock Health Sciences Trust during the 3rd quarter worth approximately $204,000. AlphaStar Capital Management LLC acquired a new position in BlackRock Health Sciences Trust during the 4th quarter worth approximately $878,000. Janney Montgomery Scott LLC raised its stake in BlackRock Health Sciences Trust by 40.5% during the 4th quarter. Janney Montgomery Scott LLC now owns 32,787 shares of the company’s stock worth $1,244,000 after buying an additional 9,455 shares during the period. Consolidated Portfolio Review Corp raised its stake in BlackRock Health Sciences Trust by 7.2% during the 3rd quarter. Consolidated Portfolio Review Corp now owns 42,574 shares of the company’s stock worth $1,785,000 after buying an additional 2,853 shares during the period. Finally, Wolverine Asset Management LLC raised its stake in BlackRock Health Sciences Trust by 42.4% during the 3rd quarter. Wolverine Asset Management LLC now owns 85,565 shares of the company’s stock worth $3,588,000 after buying an additional 25,457 shares during the period.
BlackRock Health Sciences Trust Price Performance
Shares of BlackRock Health Sciences Trust stock opened at $40.66 on Friday. BlackRock Health Sciences Trust has a 52 week low of $36.87 and a 52 week high of $42.73. The business has a 50 day moving average price of $39.22 and a 200-day moving average price of $40.44.
BlackRock Health Sciences Trust Announces Dividend
About BlackRock Health Sciences Trust
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Further Reading
- Five stocks we like better than BlackRock Health Sciences Trust
- What is a buyback in stocks? A comprehensive guide for investors
- Silicon Valley’s Sleeping Giant? Intel’s Comeback in Focus
- Where Do I Find 52-Week Highs and Lows?
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.